Etiopathology of Atopic Dermatitis: Immunological Aspects of Dendritic Cells (DCs) and Innate Lymphoid Cells (ILCs)

[1]  Y. Kataoka,et al.  Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016 , 2016, The Journal of dermatology.

[2]  Mayte Suárez-Fariñas,et al.  Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling , 2016, The Journal of allergy and clinical immunology.

[3]  K. Kabashima,et al.  Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. , 2016, The Journal of allergy and clinical immunology.

[4]  A. Rudensky,et al.  Hallmarks of Tissue-Resident Lymphocytes , 2016, Cell.

[5]  J. Metcalf,et al.  Identification and characterization of human dendritic cell subsets in the steady state: a review of our current knowledge , 2016, Journal of Investigative Medicine.

[6]  H. Nakagawa,et al.  The first trial of CIM331, a humanized antihuman interleukin‐31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double‐blind, placebo‐controlled study , 2016, The British journal of dermatology.

[7]  T. Honda,et al.  The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. , 2015, The Journal of allergy and clinical immunology.

[8]  T. Dainichi,et al.  The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling. , 2015, The Journal of allergy and clinical immunology.

[9]  K. Kabashima,et al.  Mast cells and basophils in cutaneous immune responses , 2015, Allergy.

[10]  T. Dainichi,et al.  Classification of inflammatory skin diseases: a proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity. , 2014, Journal of dermatological science.

[11]  Jonathan R. Brestoff,et al.  Basophils Promote Innate Lymphoid Cell Responses in Inflamed Skin , 2014, The Journal of Immunology.

[12]  H. Shimizu,et al.  Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. , 2014, The Journal of allergy and clinical immunology.

[13]  T. Nomura,et al.  The panoply of αβT cells in the skin. , 2014, Journal of dermatological science.

[14]  A. T. Te Velde,et al.  Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. , 2014, The Journal of investigative dermatology.

[15]  J. Mjösberg,et al.  Update on innate lymphoid cells in atopic and non‐atopic inflammation in the airways and skin , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  P. Klenerman,et al.  Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells☆ , 2014, The Journal of allergy and clinical immunology.

[17]  C. Geisler,et al.  Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin , 2014, The British journal of dermatology.

[18]  G. Ogg,et al.  A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis , 2013, The Journal of experimental medicine.

[19]  D. Artis,et al.  Innate lymphoid cells and allergic inflammation. , 2013, Current opinion in immunology.

[20]  F. Villanova,et al.  Characterization of innate lymphoid cells (ILC) in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis , 2013, The Journal of investigative dermatology.

[21]  K. Cease,et al.  Staphylococcus δ-toxin promotes mouse allergic skin disease by inducing mast cell degranulation , 2013, Nature.

[22]  H. Spits,et al.  SnapShot: innate lymphoid cells. , 2013, Immunity.

[23]  K. Nakanishi,et al.  Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice , 2013, Proceedings of the National Academy of Sciences.

[24]  W. Paul,et al.  Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells , 2013, Nature Immunology.

[25]  K. Kabashima.  New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. , 2013, Journal of dermatological science.

[26]  M. Hepworth,et al.  TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation , 2013, Science Translational Medicine.

[27]  Hergen Spits,et al.  The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. , 2012, Immunity.

[28]  D. Artis,et al.  Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. , 2012, Current opinion in immunology.

[29]  Julia Oh,et al.  Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis , 2012, Genome research.

[30]  S. Ziegler,et al.  Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. , 2012, The Journal of allergy and clinical immunology.

[31]  B. Igyártó,et al.  Early immune events in the induction of allergic contact dermatitis , 2012, Nature Reviews Immunology.

[32]  Tetsuro Kobayashi,et al.  Langerhans cell antigen capture through tight junctions confers preemptive immunity in experimental staphylococcal scalded skin syndrome , 2011, The Journal of experimental medicine.

[33]  A. Wollenberg,et al.  Innate Immunity in Atopic Dermatitis , 2011, Clinical reviews in allergy & immunology.

[34]  K. Kabashima,et al.  Filaggrin in atopic dermatitis: flaky tail mice as a novel model for developing drug targets in atopic dermatitis. , 2011, Inflammation & allergy drug targets.

[35]  E. Wherry,et al.  Innate lymphoid cells promote lung tissue homeostasis following acute influenza virus infection , 2011, Nature immunology.

[36]  David Artis,et al.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus , 2011, Nature Immunology.

[37]  B. Stockinger,et al.  Interleukin 9 fate reporter reveals induction of innate IL-9 response in lung inflammation , 2011, Nature Immunology.

[38]  Ya-Jen Chang,et al.  Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity , 2011, Nature Immunology.

[39]  Fu-Tong Liu,et al.  IgE, Mast Cells, and Eosinophils in Atopic Dermatitis , 2011, Clinical reviews in allergy & immunology.

[40]  S. Ziegler,et al.  Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. , 2010, The Journal of allergy and clinical immunology.

[41]  David J. Erle,et al.  Systemically dispersed innate IL-13–expressing cells in type 2 immunity , 2010, Proceedings of the National Academy of Sciences.

[42]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[43]  F. Ginhoux,et al.  The origin and development of nonlymphoid tissue CD103+ DCs , 2009, The Journal of experimental medicine.

[44]  Tsutomu Takeuchi,et al.  Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.

[45]  M. Amagai,et al.  External antigen uptake by Langerhans cells with reorganization of epidermal tight junction barriers , 2009, The Journal of experimental medicine.

[46]  Frank O. Nestle,et al.  Skin immune sentinels in health and disease , 2009, Nature Reviews Immunology.

[47]  T. Werfel.  The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. , 2009, The Journal of investigative dermatology.

[48]  F. Ginhoux,et al.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells , 2008, Nature Reviews Immunology.

[49]  B. León,et al.  Monocyte‐derived dendritic cells in innate and adaptive immunity , 2008, Immunology and cell biology.

[50]  E. Devilard,et al.  The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells , 2007, The Journal of experimental medicine.

[51]  K. Hogquist,et al.  Identification of a novel population of Langerin+ dendritic cells , 2007, The Journal of experimental medicine.

[52]  F. Ginhoux,et al.  Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state , 2007, The Journal of experimental medicine.

[53]  Yong‐jun Liu,et al.  Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. , 2007, The Journal of allergy and clinical immunology.

[54]  Niamh E Mangan,et al.  Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.

[55]  Yong‐jun Liu,et al.  Thymic stromal lymphopoietin: master switch for allergic inflammation , 2006, The Journal of experimental medicine.

[56]  Yu Wang,et al.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand , 2005, The Journal of experimental medicine.

[57]  S. Saeland,et al.  Cutaneous dendritic cells. , 2005, Seminars in immunology.

[58]  J. Belisle,et al.  Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. , 2004, The Journal of clinical investigation.

[59]  E. Pamer,et al.  TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. , 2003, Immunity.

[60]  Kathleen M. Smith,et al.  Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP , 2002, Nature Immunology.

[61]  D. J. Matthews,et al.  IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. , 2000, Immunity.

[62]  G. Dranoff,et al.  Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites , 1998, Nature.

[63]  C. Akdis,et al.  Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA- memory T cells. , 1997, Journal of immunology.

[64]  J. Letterio,et al.  A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology:  The Skin of   Transforming Growth Factor β1 Null Mice Is Devoid of  Epidermal Langerhans Cells , 1996, The Journal of experimental medicine.

[65]  R. Steinman,et al.  Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. , 1995, Cellular immunology.

[66]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[67]  D. Rimm,et al.  Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin , 1994, Nature.

[68]  M. Amagai,et al.  Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin , 1993, Nature.

[69]  J. Bos,et al.  Immune dysregulation in atopic eczema. , 1992, Archives of dermatology.

[70]  M. Plaut.  Antigen-specific lymphokine secretory patterns in atopic disease. , 1990, Journal of immunology.

[71]  J. Silverberg,et al.  Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder. , 2017, The Journal of investigative dermatology.

[72]  N. Novak,et al.  Network of myeloid and plasmacytoid dendritic cells in atopic dermatitis. , 2007, Advances in experimental medicine and biology.

[73]  Yong‐jun Liu,et al.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. , 2005, Annual review of immunology.

[74]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.